Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.

Keiichiro MiyajimaHirotaka SuzukiNobuyoshi KosakaKosuke IwataniYu ImaiKeiji YasueTakafumi YanagisawaShoji KimuraKojiro TashiroShunsuke TsuzukiYusuke KoikeJun MikiSteffi YuenTakaya SasakiManabu AokiShun SatoHiroyuki TakahashiKenta MikiTakahiro Kimura

Published in: International journal of clinical oncology (2023)

The risk for secondary bladder cancer was not significantly increased after brachytherapy compared to non-irradiation therapy. However, brachytherapy patients exhibited a higher incidence of invasive bladder cancer. Therefore, meticulous follow-up is crucial for early detection and treatment of bladder cancer in such patients.

Keyphrases

high dose
prostate cancer
end stage renal disease
ejection fraction
radiation therapy
newly diagnosed
chronic kidney disease
peritoneal dialysis
low dose
stem cell transplantation
stem cells
risk factors
combination therapy
replacement therapy
muscle invasive bladder cancer
smoking cessation